Pneumonia Trials in Paris, France
Conditions / Pneumonia / Paris, France
Research into Pneumonia spans multiple therapeutic approaches and trial phases.
21 total trials for this combination
Showing top 10 of 21 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04355429 | Efficacy of Captopril in Covid-19 Patients With Severe Acute Respiratory Syndrome (SARS) CoV-2 Pneumonia (CAPTOCOVID) | UNKNOWN | PHASE2 |
| NCT04334850 | Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia | COMPLETED | NA |
| NCT00431678 | Efficacy and Safety of Sequential IV/PO Moxifloxacin in Comparison to IV Levofloxacin Plus IV Ceftriaxone Followed by PO Levofloxacin, in the Treatment of Patients With Community-acquired Pneumonia | COMPLETED | PHASE3 |
| NCT01093261 | Corticosteroid Therapy for Glucocorticoid Insufficiency Related to Traumatic Brain Injury | COMPLETED | PHASE3 |
| NCT01004445 | A Study to Determine the Correct Dose of Amikacin Which is Delivered Directly to the Lungs of Ventilated Patients as an Aerosol Via an Investigational Device Called the Pulmonary Delivery Device System (PDDS) | COMPLETED | PHASE2 |
| NCT05531149 | Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia | TERMINATED | PHASE3 |
| NCT04618042 | FX06 to Rescue Acute Respiratory Distress Syndrome During Covid-19 Pneumonia | COMPLETED | PHASE2 |
| NCT06147674 | Evaluation of VQm PHM on Pulmonary Health Parameters for ICU | UNKNOWN | — |
| NCT04439071 | A Study to Evaluate Efficacy and Safety of PTC299 (Emvododstat) in Hospitalized Participants With Coronavirus (COVID-19) | TERMINATED | PHASE2/PHASE3 |
| NCT00084071 | Tifacogin for the Treatment of Patients With Severe Community-Acquired Pneumonia | COMPLETED | PHASE3 |